Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIOGEN (DENMARK) A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   1.3% 2.1% 2.1% 4.7% 1.2% 1.1% 6.9% 6.8%   Credit score (0-100)   82 68 67 44 83 83 35 35   Credit rating   A BBB A BBB A A BBB BBB   Credit limit (mDKK)   1.8 0.0 0.0 0.0 5.7 8.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   355 325 303 260 308 260 260 260   Gross profit   53.4 325 303 260 47.0 44.2 0.0 0.0   EBITDA   17.4 2.0 4.8 -6.8 11.6 9.2 0.0 0.0   EBIT   17.4 2.0 4.8 -6.8 11.6 9.2 0.0 0.0   Pre-tax profit (PTP)   16.3 12.3 10.1 7.6 10.9 10.7 0.0 0.0   Net earnings   12.5 12.3 10.1 7.6 8.4 8.3 0.0 0.0   Pre-tax profit without non-rec. items   16.3 2.0 4.8 -6.8 10.9 10.7 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0   Shareholders equity total   92.1 104 114 122 130 139 138 138   Interest-bearing liabilities   15.1 0.0 0.0 0.0 6.7 20.5 0.0 0.0   Balance sheet total (assets)   199 211 177 243 160 199 138 138   Net Debt   -37.2 0.0 0.0 0.0 -88.9 -65.8 -138 -138     See the entire balance sheet 1.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   355 325 303 260 308 260 260 260   Net sales growth   1.6% -8.5% -6.6% -14.4% 18.4% -15.6% 0.0% 0.0%   Gross profit   53.4 325 303 260 47.0 44.2 0.0 0.0   Gross profit growth   -15.2% 508.2% -6.6% -14.4% -81.9% -6.0% -100.0% 0.0%   Employees   25 22 24 24 22 20 0 0   Employee growth %   -7.4% -12.0% 9.1% 0.0% -8.3% -9.1% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   199 211 177 243 160 199 138 138   Balance sheet change%   28.5% 6.0% -15.8% 37.2% -34.1% 23.8% -30.4% 0.0%   Added value   17.4 2.0 4.8 -6.8 11.6 9.2 0.0 0.0   Added value %   4.9% 0.6% 1.6% -2.6% 3.8% 3.5% 0.0% 0.0%   Investments   0 -0 0 0 0 0 -0 0   Net sales trend   1.0 -1.0 -2.0 -3.0 1.0 -1.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 -1.0 1.0 2.0 0.0 0.0   1.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   4.9% 0.6% 1.6% -2.6% 3.8% 3.5% 0.0% 0.0%   EBIT %   4.9% 0.6% 1.6% -2.6% 3.8% 3.5% 0.0% 0.0%   EBIT to gross profit (%)   32.5% 0.6% 1.6% -2.6% 24.8% 20.8% 0.0% 0.0%   Net Earnings %   3.5% 3.8% 3.3% 2.9% 2.7% 3.2% 0.0% 0.0%   Profit before depreciation and extraordinary items %   3.5% 3.8% 3.3% 2.9% 2.7% 3.2% 0.0% 0.0%   Pre tax profit less extraordinaries %   4.6% 0.6% 1.6% -2.6% 3.5% 4.1% 0.0% 0.0%   ROA %   9.8% 1.0% 2.5% -3.2% 5.8% 6.0% 0.0% 0.0%   ROI %   16.3% 1.3% 2.5% -3.2% 6.1% 7.3% 0.0% 0.0%   ROE %   14.6% 12.5% 9.3% 6.4% 6.7% 6.2% 0.0% 0.0%   1.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   46.3% 100.0% 100.0% 100.0% 81.4% 69.9% 100.0% 100.0%   Relative indebtedness %   30.0% 0.0% 0.0% 0.0% 9.7% 23.0% 0.0% 0.0%   Relative net indebtedness %   15.3% 0.0% 0.0% 0.0% -21.4% -10.3% -53.3% -53.3%   Net int. bear. debt to EBITDA, %   -214.3% 0.0% 0.0% 0.0% -763.8% -715.9% 0.0% 0.0%   Gearing %   16.3% 0.0% 0.0% 0.0% 5.2% 14.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.5% 0.0% 0.0% 0.0% 22.3% 0.2% 0.0% 0.0%   1.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.9 0.0 0.0 0.0 5.4 3.3 0.0 0.0   Current Ratio   1.9 0.0 0.0 0.0 5.4 3.3 0.0 0.0   Cash and cash equivalent   52.3 0.0 0.0 0.0 95.7 86.3 0.0 0.0   1.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   147.5 0.0 0.0 0.0 65.6 155.9 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   55.7% 0.0% 0.0% 0.0% 51.7% 76.2% 53.3% 53.3%   Net working capital   92.1 0.0 0.0 0.0 129.5 138.5 0.0 0.0   Net working capital %   25.9% 0.0% 0.0% 0.0% 42.1% 53.4% 0.0% 0.0%   1.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   14 15 13 11 14 13 0 0   Added value / employee   1 0 0 -0 1 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   1 0 0 -0 1 0 0 0   EBIT / employee   1 0 0 -0 1 0 0 0   Net earnings / employee   1 1 0 0 0 0 0 0